| JIGZX | VIGAX | JIGZX / VIGAX | |
| Total Expense Ratio | 1.09 | 0.05 | 2,180% |
| Annual Report Gross Expense Ratio | 1.19 | 0.05 | 2,380% |
| Fund Existence | 18 years | 26 years | - |
| Gain YTD | 6.217 | 7.072 | 88% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.64B | 394B | 0% |
| Annual Yield % from dividends | 0.00 | 0.36 | - |
| Returns for 1 year | 17.05 | 25.13 | 68% |
| Returns for 3 years | 64.90 | 88.89 | 73% |
| Returns for 5 years | 32.85 | 85.17 | 39% |
| Returns for 10 years | 147.07 | 402.82 | 37% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNNX | 82.87 | 1.52 | +1.87% |
| Janus Henderson Global Life Sciences N | |||
| ACIOX | 13.88 | N/A | N/A |
| American Century International Opps I | |||
| VIGRX | 268.95 | N/A | N/A |
| Vanguard Growth Index Investor | |||
| IVGIX | 21.70 | N/A | N/A |
| VY® Invesco Growth and Income I | |||
| TAAHX | 37.53 | N/A | N/A |
| Transamerica Multi-Managed Balanced R | |||